Influence of fatty fish intake during pregnancy in the polyunsaturated fatty acids of erythrocyte phospholipids in the mother at labor and newborn infant. 1995

P Sanjurjo, and R Matorras, and L Perteagudo
Department of Pediatrics, Cruces Hospital, PaĆ­s Vasco University, Baracaldo, Vizcaya, Spain.

BACKGROUND Assessing the relationship between fatty fish intake, the main source of N-3 polyunsaturated fatty acids and maternal and fetal levels in erythrocytes at labor. METHODS The fatty acid composition was studied in 64 mother-newborn infant pairs by means of capillar gas chromatography. Following a nutritional inquiry our population was classified as follows: superior intake group (SIG) (> 4 times fatty fish per month; 54.4 +/- 20.5 g/day), medium intake group (MIG) (2-4 per month; 16.5 +/- 4 g/day) and inferior intake group (IIG) (< 2 times per month; 4.3 +/- 4 g/day). RESULTS In erythrocyte phospholipids higher levels were observed in SIG in relation to IIG in mothers regarding eicosapentaenoic (0.56 +/- 0.3% and 0.39 +/- 0.2%; p = 0.02) and docosahexaenoic acids (6.14 +/- 1.16% and 5.4 +/- 0.98%; p = 0.02) and in newborn infants regarding eicosapentaenoic acid (0.32 +/- 0.24% and 0.17 +/- 0.09%; p < 0.01). On the other hand, SIG had lower values of arachidonic acid than IIG in mother (11.15 +/- 1.61% vs 12.83 +/- 1.86%; p < 0.01) and newborn infants (16.08 +/- 3.42% vs 17.89 +/- 2.57%; p = 0.05). CONCLUSIONS From a biochemical point of view, and taking into account the pre-existing literature, it is suggested that a minimum fatty fish intake of twice per month should be recommended (edible portion 85 g.) in order to reach the N-6/N-3 quotient usually proposed.

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D007258 Informed Consent Voluntary authorization, by a patient or research subject, with full comprehension of the risks involved, for diagnostic or investigative procedures, and for medical and surgical treatment. Consent, Informed
D009749 Nutrition Surveys A systematic collection of factual data pertaining to the nutritional status of a human population within a given geographic area. Data from these surveys are used in preparing NUTRITION ASSESSMENTS. NHANES,National Health and Nutrition Examination Survey,Nutritional Surveys,Nutrition Survey,Nutritional Survey,Survey, Nutrition,Survey, Nutritional,Surveys, Nutrition,Surveys, Nutritional
D010743 Phospholipids Lipids containing one or more phosphate groups, particularly those derived from either glycerol (phosphoglycerides see GLYCEROPHOSPHOLIPIDS) or sphingosine (SPHINGOLIPIDS). They are polar lipids that are of great importance for the structure and function of cell membranes and are the most abundant of membrane lipids, although not stored in large amounts in the system. Phosphatides,Phospholipid
D010975 Platelet Aggregation Inhibitors Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. Antiaggregants, Platelet,Antiplatelet Agent,Antiplatelet Agents,Antiplatelet Drug,Blood Platelet Aggregation Inhibitor,Blood Platelet Antagonist,Blood Platelet Antiaggregant,PAR-1 Antagonists,Platelet Aggregation Inhibitor,Platelet Antagonist,Platelet Antagonists,Platelet Antiaggregant,Platelet Antiaggregants,Platelet Inhibitor,Protease-Activated Receptor-1 Antagonists,Antiplatelet Drugs,Blood Platelet Aggregation Inhibitors,Blood Platelet Antagonists,Blood Platelet Antiaggregants,Platelet Inhibitors,Agent, Antiplatelet,Aggregation Inhibitor, Platelet,Antagonist, Blood Platelet,Antagonist, Platelet,Antiaggregant, Blood Platelet,Antiaggregant, Platelet,Drug, Antiplatelet,Inhibitor, Platelet,Inhibitor, Platelet Aggregation,PAR 1 Antagonists,Platelet Antagonist, Blood,Platelet Antiaggregant, Blood,Protease Activated Receptor 1 Antagonists
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D002849 Chromatography, Gas Fractionation of a vaporized sample as a consequence of partition between a mobile gaseous phase and a stationary phase held in a column. Two types are gas-solid chromatography, where the fixed phase is a solid, and gas-liquid, in which the stationary phase is a nonvolatile liquid supported on an inert solid matrix. Chromatography, Gas-Liquid,Gas Chromatography,Chromatographies, Gas,Chromatographies, Gas-Liquid,Chromatography, Gas Liquid,Gas Chromatographies,Gas-Liquid Chromatographies,Gas-Liquid Chromatography
D004041 Dietary Fats Fats present in food, especially in animal products such as meat, meat products, butter, ghee. They are present in lower amounts in nuts, seeds, and avocados. Fats, Dietary,Dietary Fat,Fat, Dietary
D004281 Docosahexaenoic Acids C22-unsaturated fatty acids found predominantly in FISH OILS. Docosahexaenoate,Docosahexaenoic Acid,Docosahexenoic Acids,Docosahexaenoic Acid (All-Z Isomer),Docosahexaenoic Acid Dimer (All-Z Isomer),Docosahexaenoic Acid, 3,6,9,12,15,18-Isomer,Docosahexaenoic Acid, 4,7,10,13,16,19-(All-Z-Isomer),Docosahexaenoic Acid, 4,7,10,13,16,19-(All-Z-Isomer), Cerium Salt,Docosahexaenoic Acid, 4,7,10,13,16,19-(All-Z-Isomer), Cesium Salt,Docosahexaenoic Acid, 4,7,10,13,16,19-(All-Z-Isomer), Potassium Salt,Docosahexaenoic Acid, 4,7,10,13,16,19-(Z,Z,Z,Z,Z,E-Isomer),Docosahexaenoic Acid, 4,7,10,13,16,19-Isomer,Docosahexaenoic Acid, 4,7,10,13,16,19-Isomer, Sodium Salt,Docosahexaenoic Acid, Sodium Salt,Acid, Docosahexaenoic,Acids, Docosahexaenoic,Acids, Docosahexenoic
D004912 Erythrocytes Red blood cells. Mature erythrocytes are non-nucleated, biconcave disks containing HEMOGLOBIN whose function is to transport OXYGEN. Blood Cells, Red,Blood Corpuscles, Red,Red Blood Cells,Red Blood Corpuscles,Blood Cell, Red,Blood Corpuscle, Red,Erythrocyte,Red Blood Cell,Red Blood Corpuscle

Related Publications

P Sanjurjo, and R Matorras, and L Perteagudo
November 1997, American journal of perinatology,
P Sanjurjo, and R Matorras, and L Perteagudo
July 2008, Paediatric and perinatal epidemiology,
P Sanjurjo, and R Matorras, and L Perteagudo
December 2004, Prostaglandins, leukotrienes, and essential fatty acids,
P Sanjurjo, and R Matorras, and L Perteagudo
January 1987, Advances in experimental medicine and biology,
P Sanjurjo, and R Matorras, and L Perteagudo
December 2019, International journal of epidemiology,
P Sanjurjo, and R Matorras, and L Perteagudo
January 2011, Nihon eiseigaku zasshi. Japanese journal of hygiene,
P Sanjurjo, and R Matorras, and L Perteagudo
February 2014, Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition,
P Sanjurjo, and R Matorras, and L Perteagudo
January 1980, Annales de la nutrition et de l'alimentation,
P Sanjurjo, and R Matorras, and L Perteagudo
May 2004, Lipids,
Copied contents to your clipboard!